{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T16:19:49Z","timestamp":1770913189396,"version":"3.50.1"},"reference-count":46,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.diagmicrobio.2025.117208","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T16:03:21Z","timestamp":1764173001000},"page":"117208","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Multi-centre clinical validation of the NeuMoDx HPV assay for ASC-US \/ LSIL triage"],"prefix":"10.1016","volume":"114","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-2464-3031","authenticated-orcid":false,"given":"Taeyang","family":"Chin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anja","family":"O\u0161trbenk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nick","family":"Verhavert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Poljak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizaveta","family":"Padalko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2025.117208_bib0001","unstructured":"IARC publications website - cervical cancer screening n.d. https:\/\/publications.iarc.fr\/604 (accessed June 4, 2025)."},{"key":"10.1016\/j.diagmicrobio.2025.117208_bib0002","doi-asserted-by":"crossref","first-page":"e197","DOI":"10.1016\/S2214-109X(22)00501-0","article-title":"Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative","volume":"11","author":"Singh","year":"2023","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.diagmicrobio.2025.117208_bib0003","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1056\/NEJMoa0808516","article-title":"HPV screening for cervical cancer in rural India","volume":"360","author":"Sankaranarayanan","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diagmicrobio.2025.117208_bib0004","doi-asserted-by":"crossref","first-page":"F88","DOI":"10.1016\/j.vaccine.2012.06.095","article-title":"Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer","volume":"30","author":"Arbyn","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.diagmicrobio.2025.117208_bib0005","doi-asserted-by":"crossref","first-page":"dju153","DOI":"10.1093\/jnci\/dju153","article-title":"Reassurance against future risk of precancer and cancer conferred by a negative human papillomavirus test","volume":"106","author":"Gage","year":"2014","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.diagmicrobio.2025.117208_bib0006","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0140-6736(13)62218-7","article-title":"Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials","volume":"383","author":"Ronco","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.diagmicrobio.2025.117208_bib0007","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.1038\/s41591-023-02600-4","article-title":"Benefits, harms and cost-effectiveness of cervical screening, triage and treatment strategies for women in the general population","volume":"29","author":"Simms","year":"2023","journal-title":"Nat Med"},{"key":"10.1016\/j.diagmicrobio.2025.117208_bib0008","article-title":"Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses","volume":"363","author":"Arbyn","year":"2018","journal-title":"BMJ (Online)"},{"key":"10.1016\/j.diagmicrobio.2025.117208_bib0009","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S1470-2045(18)30763-0","article-title":"Performance of human papillomavirus testing on self-collected versus clinician-collected samples for the detection of cervical intraepithelial neoplasia of grade 2 or worse: a randomised, paired screen-positive, non-inferiority trial","volume":"20","author":"Polman","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.diagmicrobio.2025.117208_bib0010","doi-asserted-by":"crossref","first-page":"100235","DOI":"10.1016\/j.lanepe.2021.100235","article-title":"Clinical performance of high-risk HPV testing on self-samples versus clinician samples in routine primary HPV screening in the Netherlands: an observational study","volume":"11","author":"Inturrisi","year":"2021","journal-title":"Lancet Reg Health - Eur"},{"key":"10.1016\/j.diagmicrobio.2025.117208_bib0011","doi-asserted-by":"crossref","first-page":"106900","DOI":"10.1016\/j.ypmed.2021.106900","article-title":"Worldwide use of HPV self-sampling for cervical cancer screening","volume":"154","author":"Serrano","year":"2022","journal-title":"Prev Med (Balt)"},{"key":"10.1016\/j.diagmicrobio.2025.117208_bib0012","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.pvr.2015.06.006","article-title":"European guidelines for quality assurance in cervical cancer screening. Summary of the supplements on HPV screening and vaccination","volume":"1","author":"von Karsa","year":"2015","journal-title":"Papillomavirus Res"},{"key":"10.1016\/j.diagmicrobio.2025.117208_bib0013","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1093\/annonc\/mdp471","article-title":"European guidelines for quality assurance in cervical cancer screening. Second edition-summary document","volume":"21","author":"Arbyn","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1016\/j.diagmicrobio.2025.117208_bib0014","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1001\/jama.2018.10897","article-title":"Screening for cervical cancer us preventive services task force recommendation statement","volume":"320","author":"Curry","year":"2018","journal-title":"JAMA - J Am Med Assoc"},{"key":"10.1016\/j.diagmicrobio.2025.117208_bib0015","unstructured":"WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention n.d. https:\/\/www.who.int\/publications\/i\/item\/9789240030824 (accessed June 4, 2025)."},{"key":"10.1016\/j.diagmicrobio.2025.117208_bib0016","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.cmi.2019.09.006","article-title":"Primary HPV-based cervical cancer screening in Europe: implementation status, challenges, and future plans","volume":"26","author":"Maver","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.diagmicrobio.2025.117208_bib0017","doi-asserted-by":"crossref","first-page":"e1115","DOI":"10.1016\/S2214-109X(22)00241-8","article-title":"Cervical cancer screening programmes and age-specific coverage estimates for 202 countries and territories worldwide: a review and synthetic analysis","volume":"10","author":"Bruni","year":"2022","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.diagmicrobio.2025.117208_bib0018","doi-asserted-by":"crossref","unstructured":"ASCUS-LSIL Triage Study (ALTS) Group. Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. Am J Obs Gynecol 2003;188:1383\u201392. https:\/\/doi.org\/10.1067\/mob.2003.457.","DOI":"10.1067\/mob.2003.457"},{"key":"10.1016\/j.diagmicrobio.2025.117208_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcv.2024.105671","article-title":"2023 global inventory of commercial molecular tests for human papillomaviruses (HPV)","volume":"172","author":"Poljak","year":"2024","journal-title":"J Clin Virol"},{"key":"10.1016\/j.diagmicrobio.2025.117208_bib0020","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/ijc.24010","article-title":"Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older","volume":"124","author":"Meijer","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1016\/j.diagmicrobio.2025.117208_bib0021","unstructured":"Validated HPV tests usable in cervical cancer screening on clinician-collected cervical specimens n.d. https:\/\/www.hpvworld.com\/articles\/validated-hpv-screening-tests:-the-importance-of-validation\/ (accessed June 4, 2025)."},{"key":"10.1016\/j.diagmicrobio.2025.117208_bib0022","doi-asserted-by":"crossref","first-page":"893","DOI":"10.3390\/v14050893","article-title":"Clinical validation of the fully automated NeuMoDx HPV assay for cervical cancer screening","volume":"14","author":"Heideman","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.diagmicrobio.2025.117208_bib0023","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/ijc.27636","article-title":"The APTIMA HPV assay versus the hybrid capture 2 test in triage of women with ASC-US or LSIL cervical cytology: a meta-analysis of the diagnostic accuracy","volume":"132","author":"Arbyn","year":"2013","journal-title":"Int J Cancer"},{"key":"10.1016\/j.diagmicrobio.2025.117208_bib0024","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/S1470-2045(22)00294-7","article-title":"Accuracy and effectiveness of HPV mRNA testing in cervical cancer screening: a systematic review and meta-analysis","volume":"23","author":"Arbyn","year":"2022","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.diagmicrobio.2025.117208_bib0025","article-title":"Alinity m HR HPV assay fulfills criteria for human papillomavirus test requirements in cervical cancer screening settings","volume":"58","author":"Valen\u010dak","year":"2020","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2025.117208_bib0026","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00286-21","article-title":"Clinical and analytical evaluation of the alinity m HR HPV assay within the VALGENT-3 framework","volume":"59","author":"Dhillon","year":"2021","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2025.117208_bib0027","first-page":"43","article-title":"The abbott realtime high risk HPV test is a clinically validated human papillomavirus assay for triage in the referral population and use in primary cervical cancer screening in women 30 years and older: a review of validation studies","volume":"22","author":"Poljak","year":"2013","journal-title":"Acta Dermatovenerol Alp Pannonica Adriat"},{"key":"10.1016\/j.diagmicrobio.2025.117208_bib0028","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2012.12.003","article-title":"APTIMA HPV assay performance in women with atypical squamous cells of undetermined significance cytology results","volume":"208:","author":"Stoler","year":"2013","journal-title":"Am J Obs Gynecol"},{"key":"10.1016\/j.diagmicrobio.2025.117208_bib0029","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1111\/j.1471-0528.2012.03444.x","article-title":"Accuracy of colposcopy-directed punch biopsies: a systematic review and meta-analysis","volume":"119","author":"Underwood","year":"2012","journal-title":"BJOG"},{"key":"10.1016\/j.diagmicrobio.2025.117208_bib0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0026022","article-title":"HPV E6\/E7 mRNA testing is more specific than cytology in post-colposcopy follow-up of women with negative cervical biopsy","volume":"6","author":"S\u00f8rbye","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.diagmicrobio.2025.117208_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2010.05.033","article-title":"Diagnostic accuracy of guided cervical biopsies: a prospective multicenter study comparing the histopathology of simultaneous biopsy and cone specimen","volume":"203","author":"Zuchna","year":"2010","journal-title":"Am J Obs Gynecol"},{"key":"10.1016\/j.diagmicrobio.2025.117208_bib0032","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12907-017-0058-8","article-title":"Accuracy of cervical cytology: comparison of diagnoses of 100 pap smears read by four pathologists at three hospitals in Norway","volume":"17","author":"S\u00f8rbye","year":"2017","journal-title":"BMC Clin Pathol"},{"key":"10.1016\/j.diagmicrobio.2025.117208_bib0033","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1002\/ijc.28514","article-title":"Interlaboratory variation in the performance of liquid-based cytology: insights from the ATHENA trial","volume":"134","author":"Wright","year":"2014","journal-title":"Int J Cancer"},{"key":"10.1016\/j.diagmicrobio.2025.117208_bib0034","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/dc.20334","article-title":"Effect of Bethesda 2001 on reporting of atypical squamous cells (ASC) with special emphasis on atypical squamous cells-cannot rule out high grade (ASC-H)","volume":"34","author":"Simsir","year":"2006","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.diagmicrobio.2025.117208_bib0035","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1016\/j.jcv.2015.11.015","article-title":"Triage of HPV positive women in cervical cancer screening","volume":"76","author":"Wentzensen","year":"2016","journal-title":"J Clin Virol"},{"key":"10.1016\/j.diagmicrobio.2025.117208_bib0036","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3390\/vaccines11020284","article-title":"Low-grade cervical intraepithelial neoplasia (CIN1) evolution: analysis of opportunistic preventive vaccination role","volume":"11","author":"Gardella","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.diagmicrobio.2025.117208_bib0037","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1067\/mob.2003.461","article-title":"Prospective follow-up suggests similar risk of subsequent cervical intraepithelial neoplasia grade 2 or 3 among women with cervical intraepithelial neoplasia grade 1 or negative colposcopy and directed biopsy","volume":"188","author":"Cox","year":"2003","journal-title":"Am J Obs Gynecol"},{"key":"10.1016\/j.diagmicrobio.2025.117208_bib0038","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/1471-0528.16081","article-title":"Conservative management of women with cervical intraepithelial neoplasia grade 2 in Denmark: a cohort study","volume":"127","author":"Skorstengaard","year":"2020","journal-title":"BJOG"},{"key":"10.1016\/j.diagmicrobio.2025.117208_bib0039","first-page":"1","article-title":"Risk stratification and conservative management of women aged 25\u201340 years with cervical intraepithelial neoplasia grade 2(CIN2)","volume":"25","author":"Wang","year":"2025","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2025.117208_bib0040","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S1470-2045(08)70103-7","article-title":"Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study","volume":"9","author":"McCredie","year":"2008","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.diagmicrobio.2025.117208_bib0041","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/LGT.0000000000000604","article-title":"The Natural History of cervical intraepithelial Neoplasia grades 1, 2, and 3: a systematic review and Meta-analysis","volume":"25","author":"Loopik","year":"2021","journal-title":"J Low Genit Tract Dis"},{"key":"10.1016\/j.diagmicrobio.2025.117208_bib0042","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.1002\/ijc.30032","article-title":"Evaluating HPV-negative CIN2+ in the ATHENA trial","volume":"138","author":"Petry","year":"2016","journal-title":"Int J Cancer"},{"key":"10.1016\/j.diagmicrobio.2025.117208_bib0043","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jcv.2016.06.015","article-title":"A comparison of different human papillomavirus tests in PreservCyt versus SurePath in a referral population\u2014predictors 4","volume":"82","author":"Cuzick","year":"2016","journal-title":"J Clin Virol"},{"key":"10.1016\/j.diagmicrobio.2025.117208_bib0044","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1016\/j.jcv.2015.09.014","article-title":"VALGENT: a protocol for clinical validation of human papillomavirus assays","volume":"76","author":"Arbyn","year":"2016","journal-title":"J Clin Virol"},{"key":"10.1016\/j.diagmicrobio.2025.117208_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcv.2024.105649","article-title":"Validation of the clinical performance and reproducibility of the NeuMoDx HPV assay self-sample workflow","volume":"171","author":"Heideman","year":"2024","journal-title":"J Clin Virol"},{"key":"10.1016\/j.diagmicrobio.2025.117208_bib0046","unstructured":"Global strategy to accelerate the elimination of cervical cancer as a public health problem 2020."}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889325005309?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889325005309?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T15:30:19Z","timestamp":1770910219000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889325005309"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S0732889325005309"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2025.117208","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multi-centre clinical validation of the NeuMoDx HPV assay for ASC-US \/ LSIL triage","name":"articletitle","label":"Article Title"},{"value":"Diagnostic Microbiology and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2025.117208","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117208"}}